Venture investment in biotech can be a long, arduous, high-risk undertaking. But two scientists from UCLA and Caltech have found a way to boost the cancer drug development pipeline.
Their platform, 1200 Pharma, taps into medical and scientific breakthroughs to help bring potential cancer drugs to patients in record time. Today, the platform is able to accelerate the pace at which drugs are created and potentially bring more therapeutics to market. READ MORE